Ledger.Open graph →
SEC Form D · filed July 10, 2025

Pelthos Therapeutics Inc

Offering
$50.1M
Sold
$50.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Sai Rangarao · Durham, NCExecEzra Friedberg · Durham, NCDirectorFrancis Knuettel Ii · Durham, NCExecPeter Greenleaf · Durham, NCDirectorScott Plesha · Durham, NCExec · DirectorMatthew Pauls · Durham, NCDirectorTodd Davis · Durham, NCDirectorRichard Malamut · Durham, NCDirectorRichard Baxter · Durham, NCDirectorMatthew Pauls · Durham, NCDirectorTodd Davis · Durham, NCDirectorSai Rangarao · Durham, NCExecPeter Greenleaf · Durham, NCDirectorRichard Malamut · Durham, NCDirectorScott Plesha · Durham, NCExec · DirectorRichard Baxter · Durham, NCDirectorEzra Friedberg · Durham, NCDirectorFrancis Knuettel Ii · Durham, NCExecRichard B. Manchester · Laguna Beach, CADirectorMark Szporka · Orlando, FLDirectorRandy Lubinsky · Orlando, FLDirectorDavid Fleming · Orlando, FLExec · DirectorHugh H. Williamson · Denver, COExecSteven M. Bragg · Denver, CODirectorSamuel J. Camarata · Denver, COExecJack H. Jacobs · Denver, CODirectorTrusten A. Mcartor · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗